Meddo is a technology company.
Meddo has raised $3.0M across 1 funding round.
Meddo has raised $3.0M in total across 1 funding round.
Meddo has raised $3.0M in total across 1 funding round.
Meddo's investors include Merak Ventures, Alkemi Growth Capital, Picus Capital.
Meddo is a healthcare technology startup founded in 2018 in Gurugram, India, operating as a tech-enabled clinic chain aggregator that connects patients with services like diagnostics, clinics, and doctor consultations on a single platform.[1][2] It serves patients seeking integrated healthcare access, solving the problem of fragmented services by providing a unified interface for bookings and management, with reported revenue of ₹4.5 Cr+ in FY23 and total funding exceeding $12 Mn in a Pre-Series A stage as of 2021.[1] The company has grown to 191 employees and maintains steady web traffic around 4K monthly visits.[1]
Note: Search results also reference a separate entity at meddo.io, a strategic planning software tool for aligning organizational vision with execution, targeted at business leaders.[3][4][6] This appears distinct from the Indian healthtech firm, likely due to naming overlap; the analysis below focuses on the primary healthtech company matching the query's context.[1][2]
Meddo was founded in 2018 by Arctern Healthcare Private Limited as a platform to aggregate clinic chains and streamline patient access to healthcare services.[1][2] Key early milestones include starting revenue generation in August 2019 with accelerated growth from select partner institutions, demonstrating market potential.[2] In February 2019, it won "Start-up of the Year in Healthcare" by Medgate India, awarded by a senior drug controller.[2] By June 2019, the founding team expanded with experienced hires from healthcare institutions like HCAC and global retail like Walmart, bringing over 50 years of combined expertise.[2] Pivotal traction came from these partnerships, leading to a last funding round on January 7, 2021.[1]
Meddo rides the healthtech aggregation trend in India, where digital platforms address fragmented healthcare access amid rising demand for convenient diagnostics and consultations post-pandemic.[1][2] Timing aligns with India's booming healthtech sector, fueled by urbanization, smartphone penetration, and investor interest—evident in its Pre-Series A funding amid a market seeing explosive growth in telemedicine and clinic networks.[1] Favorable forces include government digital health initiatives and consumer shift to on-demand services, positioning Meddo to capture share in a $100 Bn+ opportunity. It influences the ecosystem by deepening partner integrations, standardizing patient experiences, and scaling efficient care delivery.[2]
Meddo's momentum—₹4.5 Cr+ revenue, steady team growth to 191, and prior funding—positions it for Series A pursuit or expansion into adjacent services like telehealth or pharmacy aggregation.[1] Trends like AI-driven personalization and pan-India clinic networks will shape its path, amplifying impact in underserved markets. Its influence may evolve from aggregator to full-stack healthtech leader, potentially redefining patient-clinic interactions as adoption accelerates. This builds on its core strength: simplifying healthcare in a high-growth Indian landscape.[1][2]
Meddo has raised $3.0M across 1 funding round. Most recently, it raised $3.0M Seed in September 2019.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 1, 2019 | $3.0M Seed | Merak Ventures, Alkemi Growth Capital, Picus Capital |